5-Ph-IAA - Moligand™, ≥99% , CAS No.168649-23-8
Disponible
SKU
P650834
5-Ph-IAA is a derivative of IAA. 5-Ph-IAA, a ligand, establishes the auxin-inducible degron 2 ( AID2 ) system together with an OsTIR1 (F74G) mutant. AID2 induces rapid and efficient depletion of mAID-fused proteins to study protein function in living cells, causing tumor suppression.
In Vitro
5-Ph-IAA (1 μM; 6 hours) leads to DHC1-mAC degradation in HCT116 cells constitutively expressing OsTIR1(F74G), which means the AID2 system better than the original AID system in generating conditional mutant cell lines. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: HCT116 cells Concentration: 1 µM Incubation Time: 6 hours Result: Depleted DHC1-mAC efficiently in HCT116 cells constitutively expressing OsTIR1(F74G).
In Vivo
5-Ph-IAA (0-10 mg/kg; intraperitoneally injection; every day; 7 days), used for the AID2 system, is sufficient to deplete mAID-BRD4 and TOP2A-mAC, leading to tumour suppression . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Balb/c-nu female mice (7 weeks old; 16–20 g ) bearing mAID-BRD4 and TOP2A-mAC xenograft tumours cells Dosage: 0 mg/kg, 1 mg/kg, 3 mg/kg and 10 mg/kg Administration: Intraperitoneally injection; every day; 7 days Result: Displayed significant tumour suppression of mAID-BRD4 xenografts and TOP2A-mAC xenografts.
Form:Solid
Más Información
| CAS | 168649-23-8 |
|---|---|
| Sinónimos | starbld0014027 | HY-134653 | MS-23552 | PD158918 | 2-(5-phenyl-1H-indol-3-yl)acetic acid | 5-Ph-IAA | AT34792 | AKOS022555695 | 5-phenyl-indole-3-acetic acid | 5-Phenyl-1H-indole-3-acetic acid | DTXSID80570014 | SCHEMBL23701757 | GLXC-25859 | EX-A6742 | ( |
| Especificaciones y pureza | Moligand™, ≥99% |
| Condiciones de almacenamiento de almacenamiento | Protected from light,Store at -20°C |
| Enviado en | Ice chest + Ice pads |
| Product Description | 5-Ph-IAA is a derivative of IAA. 5-Ph-IAA, a ligand, establishes the auxin-inducible degron 2 ( AID2 ) system together with an OsTIR1 (F74G) mutant. AID2 induces rapid and efficient depletion of mAID-fused proteins to study protein function in living cells, causing tumor suppression. In Vitro 5-Ph-IAA (1 μM; 6 hours) leads to DHC1-mAC degradation in HCT116 cells constitutively expressing OsTIR1(F74G), which means the AID2 system better than the original AID system in generating conditional mutant cell lines. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: HCT116 cells Concentration: 1 µM Incubation Time: 6 hours Result: Depleted DHC1-mAC efficiently in HCT116 cells constitutively expressing OsTIR1(F74G). In Vivo 5-Ph-IAA (0-10 mg/kg; intraperitoneally injection; every day; 7 days), used for the AID2 system, is sufficient to deplete mAID-BRD4 and TOP2A-mAC, leading to tumour suppression . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Balb/c-nu female mice (7 weeks old; 16–20 g ) bearing mAID-BRD4 and TOP2A-mAC xenograft tumours cells Dosage: 0 mg/kg, 1 mg/kg, 3 mg/kg and 10 mg/kg Administration: Intraperitoneally injection; every day; 7 days Result: Displayed significant tumour suppression of mAID-BRD4 xenografts and TOP2A-mAC xenografts. Form:Solid |
| Pubchem Sid | 528761295 |
| Solubilidad | DMSO |
| Sensibilidad | Light sensitive；Heat sensitive |
| PubChem CID | 15207491 |
Reseñas
Reseñas de cliente
¡Hemos encontrado otros productos que te pueden gustar!
-
5-Ph-IAADesde 359,90 US$
Remind me later